Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brunner

Showing results (411-420 of 427) with videos related to

Pageof 43
Sort By:
The EPMA Journal|December 14, 2019
Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised careMatthew Barrett, Josiane Boyne, Julia Brandts, et al.
European Journal of Heart Failure|January 11, 2020
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin TAlberto Aimo, James L Januzzi, Giuseppe Vergaro, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
The development of aperiodic neural activity in the human brainZachariah R Cross, Samantha M Gray, Adam J O Dede, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
Nature Human Behaviour|July 16, 2025
The development of aperiodic neural activity in the human brainZachariah R Cross, Samantha M Gray, Adam J O Dede, et al.
ESC Heart Failure|December 8, 2023
Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HFPascal R D Clephas, Jishnu Malgie, Jeroen Schaap, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
ESC Heart Failure|May 5, 2022
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failureGiuseppe Vergaro, Francesco Gentile, Alberto Aimo, et al.
JACC. Heart Failure|July 11, 2021
NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index CategoriesGiuseppe Vergaro, Francesco Gentile, Laura M G Meems, et al.
Pageof 43

Showing results (411-420 of 427) with videos related to

Sort By:
Pageof 43
The EPMA Journal|December 14, 2019
Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised careMatthew Barrett, Josiane Boyne, Julia Brandts, et al.
European Journal of Heart Failure|January 11, 2020
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin TAlberto Aimo, James L Januzzi, Giuseppe Vergaro, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
The development of aperiodic neural activity in the human brainZachariah R Cross, Samantha M Gray, Adam J O Dede, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
Nature Human Behaviour|July 16, 2025
The development of aperiodic neural activity in the human brainZachariah R Cross, Samantha M Gray, Adam J O Dede, et al.
ESC Heart Failure|December 8, 2023
Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HFPascal R D Clephas, Jishnu Malgie, Jeroen Schaap, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
ESC Heart Failure|May 5, 2022
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failureGiuseppe Vergaro, Francesco Gentile, Alberto Aimo, et al.
JACC. Heart Failure|July 11, 2021
NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index CategoriesGiuseppe Vergaro, Francesco Gentile, Laura M G Meems, et al.
Pageof 43